Skip to main content
China licenses Genus' biotech pigs
5/17/2019

Beijing Capital Agribusiness has acquired the license to Britain-based Genus' virus-resistant biotech pigs. Under the terms of the deal, Genus will get upfront and milestone payments of $20 million, and Beijing Shou Nong Future Bio-Tech, which will soon be launched by BCA, will fund the development of the pigs, which are resistant to porcine reproductive and respiratory syndrome, and seek its regulatory approval in China.

Full Story: